Loading…
AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice
Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein...
Saved in:
Published in: | American journal of hypertension 2009-07, Vol.22 (7), p.784-791 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103 |
---|---|
cites | cdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103 |
container_end_page | 791 |
container_issue | 7 |
container_start_page | 784 |
container_title | American journal of hypertension |
container_volume | 22 |
creator | Iwai, Masaru Tomono, Yumiko Inaba, Shinji Kanno, Harumi Senba, Izumi Mogi, Masaki Horiuchi, Masatsugu |
description | Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model. |
doi_str_mv | 10.1038/ajh.2009.85 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67394382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1038/ajh.2009.85</oup_id><sourcerecordid>2709944751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</originalsourceid><addsrcrecordid>eNqF0c2LEzEUAPAgiltXT95lQPQiU_M1k5lj2aordFeQ-oGXkHl9YVOnmdkkA_a_N6WlohdzSCD88l7ee4Q8Z3TOqGjemu3dnFPazpvqAZmxVrJScV49JDPatFWpaM0uyJMYt5RSWdfsMbnISErOxYzExZoXnxFwTEMolmgdOPSwLxYpoZ9MwlgsNm4cYJ-wWDprMaBPziQ3-ML4TX4DAU38y91Ouw5D4XwOc4dhiNDnPTkobhzgU_LImj7is9N5Sb68f7e-ui5Xnz58vFqsShC8TeWmbaqm7iiCaQWXVWcZhVaJWlJqESupDBeMo1QAmO_BohRUSJtX1-XWXJLXx7hjGO4njEnvXATse-NxmKKulWilaHiGL_-B22EKPv9NM8plIyQVdVZvjgpyQTGg1WNwOxP2GenDJHSehD5MQjdV1i9OMaduh5s_9tT6DF6dgIlgehuMBxfPjjMlFM25z1UM0_ifjOURupjw15ma8PNQqar09fcfen27XK7qm2_6q_gNfaisyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024834036</pqid></control><display><type>article</type><title>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</title><source>Oxford Journals Online</source><creator>Iwai, Masaru ; Tomono, Yumiko ; Inaba, Shinji ; Kanno, Harumi ; Senba, Izumi ; Mogi, Masaki ; Horiuchi, Masatsugu</creator><creatorcontrib>Iwai, Masaru ; Tomono, Yumiko ; Inaba, Shinji ; Kanno, Harumi ; Senba, Izumi ; Mogi, Masaki ; Horiuchi, Masatsugu</creatorcontrib><description>Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>EISSN: 1879-1905</identifier><identifier>DOI: 10.1038/ajh.2009.85</identifier><identifier>PMID: 19444223</identifier><identifier>CODEN: AJHYE6</identifier><language>eng</language><publisher>Basingstoke: Oxford University Press</publisher><subject>Adipocytes - physiology ; Adipose Tissue - drug effects ; Adipose Tissue - pathology ; Angiotensin II Type 1 Receptor Blockers - pharmacology ; Angiotensin II Type 2 Receptor Blockers ; Animals ; Apolipoproteins E - genetics ; Arterial hypertension. Arterial hypotension ; Atherosclerosis - pathology ; Atherosclerosis - physiopathology ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cell Count ; Cell Differentiation - physiology ; Cholesterol, Dietary - administration & dosage ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; Insulin Receptor Substrate Proteins - metabolism ; Male ; Medical sciences ; Mice ; Mice, Knockout ; NADPH Oxidases - metabolism ; Receptor, Angiotensin, Type 2 - deficiency ; Receptor, Angiotensin, Type 2 - physiology ; Tetrazoles - pharmacology ; Valine - analogs & derivatives ; Valine - pharmacology ; Valsartan</subject><ispartof>American journal of hypertension, 2009-07, Vol.22 (7), p.784-791</ispartof><rights>American Journal of Hypertension, Ltd. © 2009 by the American Journal of Hypertension, Ltd. 2009</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Jul 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</citedby><cites>FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21737048$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19444223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwai, Masaru</creatorcontrib><creatorcontrib>Tomono, Yumiko</creatorcontrib><creatorcontrib>Inaba, Shinji</creatorcontrib><creatorcontrib>Kanno, Harumi</creatorcontrib><creatorcontrib>Senba, Izumi</creatorcontrib><creatorcontrib>Mogi, Masaki</creatorcontrib><creatorcontrib>Horiuchi, Masatsugu</creatorcontrib><title>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</title><title>American journal of hypertension</title><addtitle>AJH</addtitle><description>Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model.</description><subject>Adipocytes - physiology</subject><subject>Adipose Tissue - drug effects</subject><subject>Adipose Tissue - pathology</subject><subject>Angiotensin II Type 1 Receptor Blockers - pharmacology</subject><subject>Angiotensin II Type 2 Receptor Blockers</subject><subject>Animals</subject><subject>Apolipoproteins E - genetics</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Atherosclerosis - pathology</subject><subject>Atherosclerosis - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cell Count</subject><subject>Cell Differentiation - physiology</subject><subject>Cholesterol, Dietary - administration & dosage</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>Insulin Receptor Substrate Proteins - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>NADPH Oxidases - metabolism</subject><subject>Receptor, Angiotensin, Type 2 - deficiency</subject><subject>Receptor, Angiotensin, Type 2 - physiology</subject><subject>Tetrazoles - pharmacology</subject><subject>Valine - analogs & derivatives</subject><subject>Valine - pharmacology</subject><subject>Valsartan</subject><issn>0895-7061</issn><issn>1941-7225</issn><issn>1879-1905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqF0c2LEzEUAPAgiltXT95lQPQiU_M1k5lj2aordFeQ-oGXkHl9YVOnmdkkA_a_N6WlohdzSCD88l7ee4Q8Z3TOqGjemu3dnFPazpvqAZmxVrJScV49JDPatFWpaM0uyJMYt5RSWdfsMbnISErOxYzExZoXnxFwTEMolmgdOPSwLxYpoZ9MwlgsNm4cYJ-wWDprMaBPziQ3-ML4TX4DAU38y91Ouw5D4XwOc4dhiNDnPTkobhzgU_LImj7is9N5Sb68f7e-ui5Xnz58vFqsShC8TeWmbaqm7iiCaQWXVWcZhVaJWlJqESupDBeMo1QAmO_BohRUSJtX1-XWXJLXx7hjGO4njEnvXATse-NxmKKulWilaHiGL_-B22EKPv9NM8plIyQVdVZvjgpyQTGg1WNwOxP2GenDJHSehD5MQjdV1i9OMaduh5s_9tT6DF6dgIlgehuMBxfPjjMlFM25z1UM0_ifjOURupjw15ma8PNQqar09fcfen27XK7qm2_6q_gNfaisyQ</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Iwai, Masaru</creator><creator>Tomono, Yumiko</creator><creator>Inaba, Shinji</creator><creator>Kanno, Harumi</creator><creator>Senba, Izumi</creator><creator>Mogi, Masaki</creator><creator>Horiuchi, Masatsugu</creator><general>Oxford University Press</general><general>Nature Publishing Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</title><author>Iwai, Masaru ; Tomono, Yumiko ; Inaba, Shinji ; Kanno, Harumi ; Senba, Izumi ; Mogi, Masaki ; Horiuchi, Masatsugu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adipocytes - physiology</topic><topic>Adipose Tissue - drug effects</topic><topic>Adipose Tissue - pathology</topic><topic>Angiotensin II Type 1 Receptor Blockers - pharmacology</topic><topic>Angiotensin II Type 2 Receptor Blockers</topic><topic>Animals</topic><topic>Apolipoproteins E - genetics</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Atherosclerosis - pathology</topic><topic>Atherosclerosis - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cell Count</topic><topic>Cell Differentiation - physiology</topic><topic>Cholesterol, Dietary - administration & dosage</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>Insulin Receptor Substrate Proteins - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>NADPH Oxidases - metabolism</topic><topic>Receptor, Angiotensin, Type 2 - deficiency</topic><topic>Receptor, Angiotensin, Type 2 - physiology</topic><topic>Tetrazoles - pharmacology</topic><topic>Valine - analogs & derivatives</topic><topic>Valine - pharmacology</topic><topic>Valsartan</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwai, Masaru</creatorcontrib><creatorcontrib>Tomono, Yumiko</creatorcontrib><creatorcontrib>Inaba, Shinji</creatorcontrib><creatorcontrib>Kanno, Harumi</creatorcontrib><creatorcontrib>Senba, Izumi</creatorcontrib><creatorcontrib>Mogi, Masaki</creatorcontrib><creatorcontrib>Horiuchi, Masatsugu</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwai, Masaru</au><au>Tomono, Yumiko</au><au>Inaba, Shinji</au><au>Kanno, Harumi</au><au>Senba, Izumi</au><au>Mogi, Masaki</au><au>Horiuchi, Masatsugu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice</atitle><jtitle>American journal of hypertension</jtitle><addtitle>AJH</addtitle><date>2009-07</date><risdate>2009</risdate><volume>22</volume><issue>7</issue><spage>784</spage><epage>791</epage><pages>784-791</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><eissn>1879-1905</eissn><coden>AJHYE6</coden><abstract>Background Previous reports indicated that blockade of AT1 receptor stimulation attenuated adipocyte dysfunction. However, the effects of AT2 receptor stimulation on adipose tissue were not yet clear. In the present study, we examined the adipose tissue dysfunction in atherosclerotic apolipoprotein E knockout (ApoEKO) mice with AT2 receptor deficiency. Methods Male ApoEKO and AT2 receptor/ApoE knockout (AT2/ApoEKO) mice at 6 weeks of age were treated with a normal diet or a high-cholesterol diet (HCD: 1.25% cholesterol). Markers for adipocyte differentiation and inflammation in adipose tissue were assayed with real-time reverse-transcription-PCR and western blot. Results Compared with ApoEKO mice, AT2/ApoEKO mice with a normal diet showed only a decrease in expression of adiponectin and CCAAT/enhancer binding protein δ (C/EBPδ) in epididymal adipose tissue without changes in body weight, adipose tissue weight, and adipocyte number even at 6 months of age. After HCD for 4 weeks, the weight of both epididymal and retroperitoneal adipose tissue in AT2/ApoEKO mice was greater than that in ApoEKO mice without a change in body weight. Plasma concentrations of cholesterol and fatty acids were higher in AT2/ApoEKO mice than in ApoEKO mice. In adipose tissue of AT2/ApoEKO mice, the adipocyte number was decreased and the expression of peroxisome proliferator–activated receptor γ (PPARγ), C/EBPα, and aP2 was lower than that in ApoEKO mice, in association with an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Conclusions These results suggest that AT2 receptor stimulation in adipose tissue is involved in the improvement of adipocyte differentiation and adipose tissue dysfunction in atherosclerotic model.</abstract><cop>Basingstoke</cop><pub>Oxford University Press</pub><pmid>19444223</pmid><doi>10.1038/ajh.2009.85</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0895-7061 |
ispartof | American journal of hypertension, 2009-07, Vol.22 (7), p.784-791 |
issn | 0895-7061 1941-7225 1879-1905 |
language | eng |
recordid | cdi_proquest_miscellaneous_67394382 |
source | Oxford Journals Online |
subjects | Adipocytes - physiology Adipose Tissue - drug effects Adipose Tissue - pathology Angiotensin II Type 1 Receptor Blockers - pharmacology Angiotensin II Type 2 Receptor Blockers Animals Apolipoproteins E - genetics Arterial hypertension. Arterial hypotension Atherosclerosis - pathology Atherosclerosis - physiopathology Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cell Count Cell Differentiation - physiology Cholesterol, Dietary - administration & dosage Clinical manifestations. Epidemiology. Investigative techniques. Etiology Insulin Receptor Substrate Proteins - metabolism Male Medical sciences Mice Mice, Knockout NADPH Oxidases - metabolism Receptor, Angiotensin, Type 2 - deficiency Receptor, Angiotensin, Type 2 - physiology Tetrazoles - pharmacology Valine - analogs & derivatives Valine - pharmacology Valsartan |
title | AT2 Receptor Deficiency Attenuates Adipocyte Differentiation and Decreases Adipocyte Number in Atherosclerotic Mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A07%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AT2%20Receptor%20Deficiency%20Attenuates%20Adipocyte%20Differentiation%20and%20Decreases%20Adipocyte%20Number%20in%20Atherosclerotic%20Mice&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Iwai,%20Masaru&rft.date=2009-07&rft.volume=22&rft.issue=7&rft.spage=784&rft.epage=791&rft.pages=784-791&rft.issn=0895-7061&rft.eissn=1941-7225&rft.coden=AJHYE6&rft_id=info:doi/10.1038/ajh.2009.85&rft_dat=%3Cproquest_cross%3E2709944751%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c329t-d98586b0eca93245bf10c9736400fee547a2312e47cce973cfe43034ffffbb103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1024834036&rft_id=info:pmid/19444223&rft_oup_id=10.1038/ajh.2009.85&rfr_iscdi=true |